Treatment of refractory thrombotic thrombocytopenic purpura using multimodality therapy including splenectomy and cyclosporine.

[1]  V. Frémeaux-Bacchi,et al.  Does hemolytic uremic syndrome differ from thrombotic thrombocytopenic purpura? , 2007, Nature Clinical Practice Nephrology.

[2]  J. George,et al.  Clinical practice. Thrombotic thrombocytopenic purpura. , 2006, The New England journal of medicine.

[3]  K. Remes,et al.  Excellent response of refractory life-threatening thrombotic thrombocytopenic purpura to cyclosporine treatment. , 2004, Clinical and laboratory haematology.

[4]  V. Rossi,et al.  Late Response to Cyclosporine in Refractory Thrombotic Thrombocytopenic Purpura , 2002, International journal of hematology.

[5]  H. Hamaguchi,et al.  [Successful treatment of refractory thrombotic thrombocytopenic purpura with cyclosporine A and splenectomy]. , 2000, [Rinsho ketsueki] The Japanese journal of clinical hematology.

[6]  M. Furlan.  von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome. , 2000, Advances in nephrology from the Necker Hospital.

[7]  Yong,et al.  Successful use of cyclosporine A in the treatment of refractory thrombotic thrombocytopenic purpura , 1998, British journal of haematology.

[8]  G. Chikkappa,et al.  Chronic relapsing thrombotic thrombocytopenic purpura: Role of therapy with cyclosporine , 1998, American journal of hematology.

[9]  J. Brennan,et al.  Refractory thrombotic thrombocytopenic purpura treated with cyclosporine , 1996, American journal of hematology.

[10]  N. Maurin,et al.  Cyclosporine for Thrombotic Thrombocytopenic Purpura , 1993, Annals of Internal Medicine.